Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $60.99MP/E –Yield –
Nuo Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Nuo Therapeutics's ebitda for the twelve months ending Dec 31, 2019 was -$879.34K. For fiscal 2021 it was -$90.67K. The highest annual figure on record is -$90.67K in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -$90.67K | – |
| FY2020 | Dec 31, 2020 | -$378.06K | – |
| FY2019 | Dec 31, 2019 | -$879.34K | – |
| FY2018 | Dec 31, 2018 | -$1.40M | – |
| FY2017 | Dec 31, 2017 | -$14.42M | – |
| FY2015 | Dec 31, 2015 | -$40.89M | – |
| FY2014 | Dec 31, 2014 | -$22.78M | – |
| FY2013 | Dec 31, 2013 | -$17.00M | – |
| FY2012 | Dec 31, 2012 | -$11.72M | – |
| FY2011 | Dec 31, 2011 | -$2.88M | – |
| FY2010 | Dec 31, 2010 | -$4.96M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | $88.27K | -51.7% |
| Q3 FY2019 | Sep 30, 2019 | -$14.81K | – |
| Q2 FY2019 | Jun 30, 2019 | -$366.17K | – |
| Q1 FY2019 | Mar 31, 2019 | -$586.63K | – |
| Q4 FY2018 | Dec 31, 2018 | $182.69K | – |
| Q3 FY2018 | Sep 30, 2018 | -$386.79K | – |
| Q2 FY2018 | Jun 30, 2018 | -$556.66K | – |
| Q1 FY2018 | Mar 31, 2018 | -$641.64K | – |
| Q4 FY2017 | Dec 31, 2017 | -$8.32M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.32M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.83M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.37M | – |
See a number that looks wrong?